Pfizer is one of the world’s premier innovative biopharmaceutical companies. 

At Pfizer, we apply science and our global resources to improve health and wellbeing at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of medicines.

Our global healthcare portfolio includes medicines and vaccines and many of the world’s best-known consumer healthcare products.

Every day, Pfizer colleagues work to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

In the UK

In the UK, Pfizer has its business headquarters in Surrey and is a major supplier of medicines to the NHS.

A number of Pfizer capabilities critical to the delivery of the company’s mid to late stage portfolio are located at Discovery Park. These include Pharmaceutical Sciences; Safety and Regulatory; Medical; Business Units; Quality Assurance; and Business Support Functions (Procurement & Operations, HR, Finance, Patents and Business Technology). As part of the Pharmaceutical Sciences operation, Pfizer’s unique pilot plant production and solid and liquid dose manufacturing are based at the site. Pfizer’s presence in Cambridge, UK (Neusentis Research Unit and Devices Centre of Emphasis) and Discovery Park offers opportunities to collaborate on industry projects and initiatives across the UK and Europe.

Historically the Sandwich site has an excellent track record of discovering new medicines to improve the health and quality of life of people suffering from critical diseases. Some of Pfizer’s most important medicines were discovered at Sandwich. They include Celsentri® (maraviroc), the first new oral class of HIV treatment in more than a decade; Revatio® (sildenafil) for the rare condition of Pulmonary Arterial Hypertension (PAH); Diflucan (fluconazole) and Vfend® (voriconazole), two life-saving anti-fungal medicines; Istin (amlodipine) and Cardura (doxazosin), for the treatment of cardiovascular disease; and Viagra® (sildenafil) for erectile dysfunction.